Development and evaluation of a single domain antibody targeting folate receptor alpha for radioligand therapy
{{output}}
Background: Folate receptor alpha (FRα) overexpression is seen in many cancers. Radioligand therapy (RLT) has emerged as a promising tool to target FRα and has been investigated previously, but further progression was limited d... ...
